About Cure Pharmaceutical
Cure Pharmaceutical is a company based in Oxnard (United States) founded in 2010.. Cure Pharmaceutical has raised $9.65 million across 10 funding rounds from investors including Gene Salkind. The company has 28 employees as of December 31, 2021. Cure Pharmaceutical has completed 2 acquisitions, including Chemistry Holdings and Sera Labs. Cure Pharmaceutical offers products and services including CUREFilm®. Cure Pharmaceutical operates in a competitive market with competitors including Lyndra, i2o Therapeutics, Biora Therapeutics, Cingulate and OnDosis, among others.
- Headquarter Oxnard, United States
- Employees 28 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cure Pharmaceutical
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.65 M (USD)
in 10 rounds
-
Latest Funding Round
$11.5 M (USD), Post-IPO
Nov 02, 2020
-
Investors
-
Employee Count
28
as on Dec 31, 2021
-
Investments & Acquisitions
Chemistry Holdings
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cure Pharmaceutical
Cure Pharmaceutical offers a comprehensive portfolio of products and services, including CUREFilm®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patented form for rapid sublingual absorption to improve medication efficacy.
Funding Insights of Cure Pharmaceutical
Cure Pharmaceutical has successfully raised a total of $9.65M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $11.5 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $11.5M
-
First Round
First Round
(25 Jul 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - Cure Pharmaceutical | Valuation |
investors |
|
| Feb, 2018 | Amount | Post-IPO - Cure Pharmaceutical | Valuation |
investors |
|
| Oct, 2016 | Amount | Series A - Cure Pharmaceutical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cure Pharmaceutical
Cure Pharmaceutical has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Gene Salkind. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
GS
Gene Salkind |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cure Pharmaceutical
Cure Pharmaceutical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Chemistry Holdings and Sera Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of health and wellness products suing cannabis
|
2018 | ||||
|
Limited information available
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cure Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cure Pharmaceutical Comparisons
Competitors of Cure Pharmaceutical
Cure Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyndra, i2o Therapeutics, Biora Therapeutics, Cingulate and OnDosis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
|
| domain | founded_year | HQ Location |
Oral drug delivery solutions are provided via liquid technology platform.
|
|
| domain | founded_year | HQ Location |
Smart pills are developed for targeted gastrointestinal drug delivery.
|
|
| domain | founded_year | HQ Location |
Cingulate is focused on developing treatments for ADHD and anxiety.
|
|
| domain | founded_year | HQ Location |
Oral drug delivery systems for individualized micro-unit dosing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cure Pharmaceutical
Frequently Asked Questions about Cure Pharmaceutical
When was Cure Pharmaceutical founded?
Cure Pharmaceutical was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Cure Pharmaceutical located?
Cure Pharmaceutical is headquartered in Oxnard, United States. It is registered at Oxnard, California, United States.
Is Cure Pharmaceutical a funded company?
Cure Pharmaceutical is a funded company, having raised a total of $9.65M across 10 funding rounds to date. The company's 1st funding round was a Series A of $80K, raised on Jul 25, 2011.
How many employees does Cure Pharmaceutical have?
As of Dec 31, 2021, the latest employee count at Cure Pharmaceutical is 28.
What does Cure Pharmaceutical do?
Cure Pharmaceutical was founded in 2010 in Oxnard, United States, focusing on pharmaceutical drug delivery innovations. Various platforms are developed, including oral thin films, liquid-based encapsulation, transdermal systems using epidermis penetration enhancers, and gastrointestinal delivery methods. Services provided encompass process development, manufacturing, and packaging design to support these technologies. Operations emphasize improved bioavailability compared to traditional forms like tablets and capsules.
Who are the top competitors of Cure Pharmaceutical?
Cure Pharmaceutical's top competitors include i2o Therapeutics, Cingulate and PLx Pharma.
What products or services does Cure Pharmaceutical offer?
Cure Pharmaceutical offers CUREFilm®.
How many acquisitions has Cure Pharmaceutical made?
Cure Pharmaceutical has made 2 acquisitions, including Chemistry Holdings, and Sera Labs.
Who are Cure Pharmaceutical's investors?
Cure Pharmaceutical has 1 investor. Key investors include Gene Salkind.